QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.108.139659v1 327/1/130    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Matsuda, T. Articles by Yanagihara, N. PubMed PubMed Citation Articles by Matsuda, T. Articles by Yanagihara, N.

CARDIOVASCULAR

Simvastatin Inhibits Catecholamine Secretion and Synthesis Induced by Acetylcholine via Blocking Na⁺ and Ca²⁺ Influx in Bovine Adrenal Medullary Cells

Department of Pharmacology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan

Simvastatin, an inhibitor of HMG-CoA reductase, is a potent inhibitor of cholesterol biosynthesis and has beneficial effects in the primary and secondary prevention of cardiovascular diseases. In this study, we report the effects of simvastatin on catecholamine secretion and synthesis in cultured bovine adrenal medullary cells used as a model of sympathetic neurons. Simvastatin inhibited catecholamine secretion induced by acetylcholine, an agonist of the nicotinic acetylcholine receptor; by veratridine, an activator of voltage-dependent Na⁺ channels; and by high K⁺, an activator of voltage-dependent Ca²⁺ channels (IC₅₀ = 3.8, 7.8, and 6.1 µM, respectively). Simvastatin also suppressed acetylcholine-induced ²²Na⁺ influx (IC₅₀ = 4.3 µM) and ⁴⁵Ca²⁺ influx (IC₅₀ = 6.1 µM), veratridine-induced ²²Na⁺ influx (IC₅₀ = 6.6 µM) and ⁴⁵Ca²⁺ influx (IC₅₀ = 12 µM), and high K⁺-induced ⁴⁵Ca²⁺ influx (IC₅₀ = 11 µM). The reduction of catecholamine secretion caused by simvastatin was not overcome by increasing the concentration of acetylcholine or by treatment with mevalonate, the first metabolite of HMG-CoA. The inhibitory effect of simvastatin on histamine-induced secretion of catecholamines was observed in the presence of extracellular Ca²⁺, but not in a Ca²⁺-free medium, suggesting that simvastatin does not interfere with histamine receptors nonselectively. Simvastatin also suppressed acetylcholine-induced [¹⁴C]catecholamine synthesis from [¹⁴C]tyrosine as well as tyrosine hydroxylase activity. These findings suggest that simvastatin inhibits catecholamine secretion and synthesis induced by acetylcholine through suppression of Na⁺ and Ca²⁺ influx in the adrenal medulla and probably in the sympathetic neurons.

Address correspondence to: Dr. Nobuyuki Yanagihara, Department of Pharmacology, University of Occupational and Environmental Health, School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan. E-mail: yanagin{at}med.uoeh-u.ac.jp